PRODUCT

°í°´¸¸Á·À» À§ÇØ Áö¼ÓÀûÀ¸·Î °í¹ÎÇϰí Çõ½ÅÇÏ¿© ÃÖ°íÀÇ Ç°ÁúÀ» Á¦°øÇÕ´Ï´Ù.

R&D reagents

Product > R&D reagents
Atracurium besylate, 98%
CAS No K027-100mg
Á¦Ç°¹øÈ£ AK Sci.(USA)
Á¦Á¶»ç ¼öÀÔ»ê
Àç°í 1 EA
±Ý¾× 126,000¿ø
Æ÷Àå´ÜÀ§





¡Ø È­Çиí : Atracurium besylate, 98%

 

¡Ø µî±Þ : APIs and Bioactives > AChR Agonists

 

¡Ø ÆÇ¸Å Æ÷Àå´ÜÀ§ : 100mg , 1g

 

¡Ø È­ÇÐ½Ä : C65H82N2O18S2

 

¡Ø CAS # : [64228-81-5]

 

 

IDENTITY
CAS Registry #: [64228-81-5]
MDL Number: MFCD00797403
MF: C65H82N2O18S2
MW: 1243.48
EINECS: 264-743-4
SPECIFICATIONS & PROPERTIES
Purity: 98%
Physical Form: White to light yellow powder
Melting Point: 87-92¡ÆC
Long-Term Storage: Store long-term at 2-8¡ÆC
Shipping: Not Regulated for Shipping

BIOLOGICAL INFO
Application(s): Neuromuscular blocking agent

REVIEW

Atracurium antagonizes the neurotransmitter action of acetylcholine by binding competitively with cholinergic receptor sites on the motor end-plate. This antagonism is inhibited, and neuromuscular block reversed, by acetylcholinesterase inhibitors such as neostigmine, edrophonium, and pyridostigmine.

Risk Description(s)
R36/37/38: Irritating to eyes, respiratory system and skin

Safety Description(s)
S24/25: Avoid contact with skin and eyes.